カテゴリー： FactMR, 世界, 医療/バイオ

PCR・リアルタイムPCR分子診断の世界市場2023年～2033年：予測・動向・分析・競争状況

◆英語タイトル：PCR and Real-time PCR Molecular Diagnostics Market By Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents, Consumables), By Application (Infectious Disease Testing, Oncology Testing, Genetic Testing), By End User (Hospitals, Diagnostic Laboratories, Academic & Research Centers) & Region – Global Market Insights 2023 to 2033

FactMRが発行した調査報告書（FACT23AP101）◆商品コード：FACT23AP101
◆発行会社（リサーチ会社）：FactMR
◆発行日：2023年1月19日
◆ページ数：約170
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ファクトエムアール社の本調査資料は、2023年から2033年までの世界のPCR・リアルタイムPCR分子診断市場の現状・動向について調査した最新レポートです。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場展望、技術別（従来型PCR、リアルタイムPCR、デジタルPCR）分析、製品別（機器、試薬、消耗品）、用途別（感染症検査、腫瘍学検査、遺伝子検査、その他）分析、エンドユーザー別（病院、診断研究所、学術研究＆研究センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況などの構成でまとめております。なお、当レポートには、Abbott Laboratories、Elekta AB Bio-Rad Laboratories, Inc.、bioMérieux SAなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場展望
・世界のPCR・リアルタイムPCR分子診断市場規模：技術別
　- 従来型PCRの市場規模
　- リアルタイムPCRの市場規模
　- デジタルPCRの市場規模
・世界のPCR・リアルタイムPCR分子診断市場規模：製品別
　- PCR・リアルタイムPCR分子診断機器の市場規模
　- PCR・リアルタイムPCR分子診断試薬の市場規模
　- PCR・リアルタイムPCR分子診断消耗品の市場規模
・世界のPCR・リアルタイムPCR分子診断市場規模：用途別
　- 感染症検査における市場規模
　- 腫瘍学検査における市場規模
　- 遺伝子検査における市場規模
　- その他用途における市場規模
・世界のPCR・リアルタイムPCR分子診断市場規模：エンドユーザー別
　- 病院における市場規模
　- 診断研究所における市場規模
　- 学術研究＆研究センターにおける市場規模
　- その他エンドユーザーにおける市場規模
・世界のPCR・リアルタイムPCR分子診断市場規模：地域別
　- 北米のPCR・リアルタイムPCR分子診断市場規模
　- ヨーロッパのPCR・リアルタイムPCR分子診断市場規模
　- アジア太平洋のPCR・リアルタイムPCR分子診断市場規模
　- 中南米のPCR・リアルタイムPCR分子診断市場規模
　- 中東/アフリカのPCR・リアルタイムPCR分子診断市場規模
・競争状況

本資料には、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、読者に実用的な洞察を提供し、熟考して市場の状況を示し、PCR・リアルタイムPCR分子診断における競争レベルを推測するのに役立ちます。

PCR and Real-time PCR Molecular Diagnostics Market – Scope of Report

A recent study by Fact.MR on the pcr and real-time pcr molecular diagnostics market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering pcr and real-time pcr molecular diagnostics.

The study also provides the dynamics responsible for influencing the future status of the pcr and real-time pcr molecular diagnostics market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the pcr and real-time pcr molecular diagnostics market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of pcr and real-time pcr molecular diagnostics across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of pcr and real-time pcr molecular diagnostics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for pcr and real-time pcr molecular diagnostics are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global pcr and real-time pcr molecular diagnostics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the pcr and real-time pcr molecular diagnostics market during the forecast period.

Country-specific valuation on demand for pcr and real-time pcr molecular diagnostics has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of pcr and real-time pcr molecular diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering pcr and real-time pcr molecular diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the pcr and real-time pcr molecular diagnostics domain.

❖ レポートの目次 ❖

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Market Analysis and Forecast, 2023-2033

5. Market Outlook

    5.1. Technology Advancement

    5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)

    5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global Market Value Forecast, by Technology

    6.1. Introduction and Definition

    6.2. Global Market Value Forecast, by Technology, 2023-2033

        6.2.1. Traditional PCR

        6.2.2. Real-time PCR

        6.2.3. Digital PCR

    6.3. Global Market Attractiveness Analysis, by Technology

7. Global Market Value (US$ Mn) Forecast, by Product

    7.1. Introduction and Definition

    7.2. Global Market Value Forecast, by Technology, 2023-2033

        7.2.1. Instruments

        7.2.2. Reagents

        7.2.3. Consumables

    7.3. Global Market Attractiveness Analysis, by Product

8. Global Market Value (US$ Mn) Forecast, by Application

    8.1. Introduction and Definition

    8.2. Global Market Value Forecast, by Technology, 2023-2033

        8.2.1. Infectious Diseases Testing

            8.2.1.1. HCV and HBV

            8.2.1.2. Sexually Transmitted Infections

            8.2.1.3. Hospital Acquired Infection

            8.2.1.4. Respiratory Infections

            8.2.1.5. Others

        8.2.2. Oncology Testing

        8.2.3. Genetic Testing

        8.2.4. Others

    8.3. Global Market Attractiveness Analysis, by Application

9. Global Market Value (US$ Mn) Forecast, by End-user

    9.1. Introduction and Definition

    9.2. Global Market Value Forecast, by End-user, 2023-2033

        9.2.1. Hospitals

        9.2.2. Diagnostic Laboratories

        9.2.3. Academic and Research Centers

        9.2.4. Others

    9.3. Global Market Attractiveness Analysis, by End-user

10. Global Market Value (US$ Mn) Forecast, by Region

    10.1. Introduction

    10.2. Global Market Value Forecast, by Region, 2023-2033

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East and Africa

    10.3. Global Market Attractiveness Analysis, by Region

11. North America Market Analysis and Forecast

    11.1. Introduction

    11.2. North America Market Value Forecast, by Technology, 2023-2033

        11.2.1. Traditional PCR

        11.2.2. Real-time PCR

        11.2.3. Digital PCR

    11.3. North America Market Value Forecast, by Product, 2023-2033

        11.3.1. Instruments

        11.3.2. Reagents

        11.3.3. Consumables

    11.4. North America Market Value Forecast, by Application, 2023-2033

        11.4.1. Infectious Diseases Testing

            11.4.1.1. HCV and HBV

            11.4.1.2. Sexually Transmitted Infections

            11.4.1.3. Hospital Acquired Infection

            11.4.1.4. Respiratory Infections

            11.4.1.5. Others

        11.4.2. Oncology Testing

        11.4.3. Genetic Testing

        11.4.4. Others

    11.5. North America Market Value Forecast, by End-user, 2023-2033

        11.5.1. Hospitals

        11.5.2. Diagnostic Laboratories

        11.5.3. Academic and Research Centers

    11.6. North America Market Value Forecast, by Country, 2023-2033

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Market Attractiveness Analysis

        11.7.1. By Technology

        11.7.2. By Product

        11.7.3. By Application

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Market Analysis and Forecast

    12.1. Introduction

    12.2. Europe Market Value Forecast, by Technology, 2023-2033

        12.2.1. Traditional PCR

        12.2.2. Real-time PCR

        12.2.3. Digital PCR

    12.3. Europe Market Value Forecast, by Product, 2023-2033

        12.3.1. Instruments

        12.3.2. Reagents

        12.3.3. Consumables

    12.4. Europe Market Value Forecast, by Application, 2023-2033

        12.4.1. Infectious Diseases Testing

            12.4.1.1. HCV and HBV

            12.4.1.2. Sexually Transmitted Infections

            12.4.1.3. Hospital Acquired Infection

            12.4.1.4. Respiratory Infections

            12.4.1.5. Others

        12.4.2. Oncology Testing

        12.4.3. Genetic Testing

        12.4.4. Others

    12.5. Europe Market Value Forecast, by End-user, 2023-2033

        12.5.1. Hospitals

        12.5.2. Diagnostic Laboratories

        12.5.3. Academic and Research Centers

    12.6. Europe Market Value Forecast, by Country/Sub-region, 2023-2033

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Market Attractiveness Analysis

        12.7.1. By Technology

        12.7.2. By Product

        12.7.3. By Application

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Market Analysis and Forecast

    13.1. Introduction

    13.2. Asia Pacific Market Value Forecast, by Technology, 2023-2033

        13.2.1. Traditional PCR

        13.2.2. Real-time PCR

        13.2.3. Digital PCR

    13.3. Asia Pacific Market Value Forecast, by Product, 2023-2033

        13.3.1. Instruments

        13.3.2. Reagents

        13.3.3. Consumables

    13.4. Asia Pacific Market Value Forecast, by Application, 2023-2033

        13.4.1. Infectious Diseases Testing

            13.4.1.1. HCV and HBV

            13.4.1.2. Sexually Transmitted Infections

            13.4.1.3. Hospital Acquired Infection

            13.4.1.4. Respiratory Infections

            13.4.1.5. Others

        13.4.2. Oncology Testing

        13.4.3. Genetic Testing

        13.4.4. Others

    13.5. Asia Pacific Market Value Forecast, by End-user, 2023-2033

        13.5.1. Hospitals

        13.5.2. Diagnostic Laboratories

        13.5.3. Academic and Research Centers

    13.6. Asia Pacific Market Value Forecast, by Country/Sub-region, 2023-2033

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia and New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Market Attractiveness Analysis

        13.7.1. By Technology

        13.7.2. By Product

        13.7.3. By Application

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Market Analysis and Forecast

    14.1. Introduction

    14.2. Latin America Market Value Forecast, by Technology, 2023-2033

        14.2.1. Traditional PCR

        14.2.2. Real-time PCR

        14.2.3. Digital PCR

    14.3. Latin America Market Value Forecast, by Product, 2023-2033

        14.3.1. Instruments

        14.3.2. Reagents

        14.3.3. Consumables

    14.4. Latin America Market Value Forecast, by Application, 2023-2033

        14.4.1. Infectious Diseases Testing

            14.4.1.1. HCV and HBV

            14.4.1.2. Sexually Transmitted Infections

            14.4.1.3. Hospital Acquired Infection

            14.4.1.4. Respiratory Infections

            14.4.1.5. Others

        14.4.2. Oncology Testing

        14.4.3. Genetic Testing

        14.4.4. Others

    14.5. Latin America Market Value Forecast, by End-user, 2023-2033

        14.5.1. Hospitals

        14.5.2. Diagnostic Laboratories

        14.5.3. Academic and Research Centers

    14.6. Latin America Market Value Forecast, by Country/Sub-region, 2023-2033

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Market Attractiveness Analysis

        14.7.1. By Technology

        14.7.2. By Product

        14.7.3. By Application

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East and Africa Market Analysis and Forecast

    15.1. Introduction

    15.2. Middle East and Africa Market Value Forecast, by Technology, 2023-2033

        15.2.1. Traditional PCR

        15.2.2. Real-time PCR

        15.2.3. Digital PCR

    15.3. Middle East and Africa Market Value Forecast, by Product, 2023-2033

        15.3.1. Instruments

        15.3.2. Reagents

        15.3.3. Consumables

    15.4. Middle East and Africa Market Value Forecast, by Application, 2023-2033

        15.4.1. Infectious Diseases Testing

            15.4.1.1. HCV and HBV

            15.4.1.2. Sexually Transmitted Infections

            15.4.1.3. Hospital Acquired Infection

            15.4.1.4. Respiratory Infections

            15.4.1.5. Others

        15.4.2. Oncology Testing

        15.4.3. Genetic Testing

        15.4.4. Others

    15.5. Middle East and Africa Market Value Forecast, by End-user, 2023-2033

        15.5.1. Hospitals

        15.5.2. Diagnostic Laboratories

        15.5.3. Academic and Research Centers

    15.6. Middle East and Africa Market Value Forecast, by Country/Sub-region, 2023-2033

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East and Africa

    15.7. Middle East and Africa Market Attractiveness Analysis

        15.7.1. By Technology

        15.7.2. By Product

        15.7.3. By Application

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by tier and size of companies)

    16.2. Global Market Position Analysis, by Company, 2020

    16.3. Company Profiles

        16.3.1. Abbott Laboratories

            16.3.1.1. Company Description

            16.3.1.2. Business Overview

            16.3.1.3. Financial Overview

            16.3.1.4. Strategic Overview

            16.3.1.5. SWOT Analysis

        16.3.2. Elekta AB Bio-Rad Laboratories, Inc.

            16.3.2.1. Company Description

            16.3.2.2. Business Overview

            16.3.2.3. Financial Overview

            16.3.2.4. Strategic Overview

            16.3.2.5. SWOT Analysis

        16.3.3. bioMérieux SA

            16.3.3.1. Company Description

            16.3.3.2. Business Overview

            16.3.3.3. Financial Overview

            16.3.3.4. Strategic Overview

            16.3.3.5. SWOT Analysis

        16.3.4. Danaher Corporation

            16.3.4.1. Company Description

            16.3.4.2. Business Overview

            16.3.4.3. Financial Overview

            16.3.4.4. Strategic Overview

            16.3.4.5. SWOT Analysis

        16.3.5. Thermo Fisher Scientific, Inc.

            16.3.5.1. Company Description

            16.3.5.2. Business Overview

            16.3.5.3. Financial Overview

            16.3.5.4. Strategic Overview

            16.3.5.5. SWOT Analysis

        16.3.6. Becton, Dickinson and Company

            16.3.6.1. Company Description

            16.3.6.2. Business Overview

            16.3.6.3. Financial Overview

            16.3.6.4. Strategic Overview

            16.3.6.5. SWOT Analysis

        16.3.7. F. Hoffmann-La Roche Ltd

            16.3.7.1. Company Description

            16.3.7.2. Business Overview

            16.3.7.3. Financial Overview

            16.3.7.4. Strategic Overview

            16.3.7.5. SWOT Analysis

        16.3.8. QIAGEN N.V.

            16.3.8.1. Company Description

            16.3.8.2. Business Overview

            16.3.8.3. Financial Overview

            16.3.8.4. Strategic Overview

            16.3.8.5. SWOT Analysis

        16.3.9. Hologic, Inc.

            16.3.9.1. Company Description

            16.3.9.2. Business Overview

            16.3.9.3. Financial Overview

            16.3.9.4. Strategic Overview

            16.3.9.5. SWOT Analysis

        16.3.10. GRIFOLS, S.A.

            16.3.10.1. Company Description

            16.3.10.2. Business Overview

            16.3.10.3. Financial Overview

            16.3.10.4. Strategic Overview

            16.3.10.5. SWOT Analysis

        16.3.11. Genomic Health

            16.3.11.1. Company Description

            16.3.11.2. Business Overview

            16.3.11.3. Financial Overview

            16.3.11.4. Strategic Overview

            16.3.11.5. SWOT Analysis

        16.3.12. Seegene, Inc.

            16.3.12.1. Company Description

            16.3.12.2. Business Overview

            16.3.12.3. Financial Overview

            16.3.12.4. Strategic Overview

            16.3.12.5. SWOT Analysis

17. Research Methodology

18. Acronyms and Assumptions Used

Table 01: Global In-vitro Diagnostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2023-2033

Table 02: Global Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 03: Global Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 04: Global Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 05: Global Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 07: Global Market Value (US$ Mn) Forecast, by Region, 2023-2033

Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023-2033

Table 09: North America Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 10: North America Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 11: North America Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 12: North America Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 13: North America Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 14: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 15: Europe Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 16: Europe Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 17: Europe Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 18: Europe Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 19: Europe Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 25: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 26: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 27: Latin America Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 28: Latin America Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 29: Latin America Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 30: Latin America Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 31: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 32: Middle East and Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 33: Middle East and Africa Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 34: Middle East and Africa Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 35: Middle East and Africa Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 36: Middle East and Africa Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 37: Middle East and Africa Market Value (US$ Mn) Forecast, by End-user, 2023-2033

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ PCR・リアルタイムPCR分子診断の世界市場2023年～2033年：予測・動向・分析・競争状況(PCR and Real-time PCR Molecular Diagnostics Market By Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents, Consumables), By Application (Infectious Disease Testing, Oncology Testing, Genetic Testing), By End User (Hospitals, Diagnostic Laboratories, Academic & Research Centers) & Region – Global Market Insights 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 心臓バイオマーカーの世界市場2023年-2033年：予測・動向・分析・競争状況
  • 細胞株開発の世界市場2023年-2033年：予測・動向・分析・競争状況
  • ペプチド感染症治療薬の世界市場2023年～2033年：予測・動向・分析・競争状況
  • 非破壊検査の世界市場2023年-2033年：予測・動向・分析・競争状況
  • 自動車用モバイルアクセサリーの世界市場2023年～2033年：予測・動向・分析・競争状況

    • ◆H&Iグローバルリサーチのお客様（例）◆